Servier partnered with Owkin to apply AI to its clinical data for drug positioning and patient stratification in oncology.

Servier wanted to improve drug positioning and patient stratification so the right treatment reaches the right patient. Owkin applied AI to Servier's clinical data on two initial projects: identifying tumour types and patient subgroups most likely to benefit from Servier assets, and exploring digital pathology to speed biomarker screening. The release gives no quantified outcomes.

Owkin is a French AI company building biology models and the K Pro AI Scientist, working with pharma on drug positioning, trial design and pathology diagnostics.

This sits in the Design & Stress-Test stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to scope, prototype and benchmark an AI use case before committing to build it — data-catalog, sandbox and evaluation platforms.